<DOC>
	<DOC>NCT01985594</DOC>
	<brief_summary>RESEARCH HYPOTHESIS -Incidence of preterm delivery is lower in women treated with oral micronized progesterone (Utrogestan) as acute tocolysis agent compare to Nifedipine group with fewer maternal side effect</brief_summary>
	<brief_title>Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor, Premature</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>â€¢ Singleton pregnancy women between 22 and 34 weeks of gestation who presented with threatened preterm labor. Multiple pregnancies Women with Preterm Prelabour Rupture of Membrane Fetal death Women with bad obstetric history Women with history of cervical incompetence Contraindication to Nifedipine such as cardiovascular disease, hyperthyroidism, severe pre eclampsia or to Utrogestan Maternal or fetal indication for immediate delivery, such as fetal distress, bleeding placenta previa, abruption placenta Contraindication for tocolysis, for example severe pre eclampsia, intrauterine growth restriction, fetal anomaly, chorioamnionitis, significant antepartum haemorrhage Cervical dilatation of 3cm or more Patients with previous tocolytic treatment during this pregnancy Women who refuse to participate in this study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>preterm labor</keyword>
</DOC>